Clinical Trial Update: Ademetionine in Obstructive Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating ademetionine for obstructive hypertrophic cardiomyopathy; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy Obstructive

Drugs mentioned

• Ademetionine (S-adenosyl-L-methionine)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM) | Phase 2 | Status: RECRUITING